Greenville Health System Cancer Institute

Greenville, South Carolina 29605

Use our guide to learn which trials are right for you!

We've found
11 trials
at this facility
Oncology Clinical Trial
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling, Phase II, III
Updated: 11/22/2016
mi
from
Greenville, SC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Locally Advanced Pancreatic Cancer Clinical Trial
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Status: Enrolling, Phase II
Updated: 2/16/2018
mi
from
Greenville, SC
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Colorectal Neoplasm Clinical Trial
DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials